Lungcare (朗开医疗)
Su Zhou Shi, China
Lungcare provides cutting edge surgical navigation system together with early stage diagnosis and therapeutical solutions for lung diseases. It is the first Asia company to obtain CFDA approval of surgical navigation system for lung diseases, with integrated solutions for both biopsy diagnosis and ablation therapy. It has developed the breakthrough technologies in the surgeries both through the bronchioles and the thorax, with complete IP rights. In 2017, the Company was awarded as “National Special Project” and obtained grant from MoST (Ministry of Science and Technology). Together with 6 leading hospitals, it has launched the world’s largest clinical trial of over 2000 patients to promote the wide application of the therapeutical solutions
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2012
- Website
- www.lungcaremed.com/index?lan=zh_CN
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Lungcare (朗开医疗)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now